YANKCOM Partnership »

Diamedica Therapeutics shares owned by YANKCOM Partnership

Quarter-by-quarter ownership of Diamedica Therapeutics (DMAC) shares owned by YANKCOM Partnership from 13F filings

Historical chart of YANKCOM Partnership investment in Diamedica Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Diamedica Therapeutics held by YANKCOM Partnership consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Diamedica Therapeutics by YANKCOM Partnership

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.6k 200 7.96

More positions owned by YANKCOM Partnership

Vanguard FTSE Developed Markets ETF Van Ftse Dev Mkt (VEA)
Vanguard Index Funds S&P 500 ETF S&p 500 Etf Shs (VOO)
Schwab Strategic Tr US Large-Cap Value ETF Us Lcap Va Etf (SCHV)
iShares Tr S&P Midcap 400 ETF Core S&p Mcp Etf (IJH)
iShares Tr Russell Top 200 Growth ETF Rus Tp200 Gr Etf (IWY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Inc Cap Stock Cl A Cap Stk Cl A (GOOGL)
Vanguard FTSE Emerging Markets ETF Ftse Emr Mkt Etf (VWO)
SPDR Portfolio Developed World Ex-US ETF Portfolio Devlpd (SPDW)
Citigroup Com New (C)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)

View all positions for YANKCOM Partnership

Top funds holding Diamedica Therapeutics

Omega Advisors
BlackRock
Millennium Management
Paragon Associates & Paragon Associates Ii Joint Venture
Vanguard Group
Geode Capital Management
First Manhattan
State Street Corporation
Bleichroeder
Northern Trust
LPL Financial
Advisor Group Holdings
CI Private Wealth
Corient IA
Members Wealth

View all funds holding Diamedica Therapeutics